PLASMASPIEGEL UND WIRKUNG VON SOTALOL-HCl AUF EKG-ZEITINTERVALLE NACH PARENTERALER APPLIKATION AN GESUNDE PROBANDEN

Translated title of the contribution: Plasma levels of Sotalol-HCl and effects on ECG intervals aftar parenteral administration in healthy volunteers

K. D. Rehm, K. Schnelle, C. J. Dyde, E. Blümner, W. Arendts

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Abstract

Sotalol (Sotalex®, Sotacor®) is a β-blocker with additional class III antiarrhythmic activity. In this study two intervenous doses of 1.5 mg/kg and 2 mg/kg body weight were administered in 8 healthy volunteers in order to determine the pharmacokinetics and ECG intervals. After a short-term infusion (5 min) plasma levels and the relevant pharmacokinetic parameters were determined. The ECG parameters (QRS, PQ, QT, QTc), blood pressure, heart rate and tolerability were also evaluated. A correlation between the plasma concentration of sotalol, the decrease in heart rate and a prolongation of the real QT interval was found for both dose levels and for a period of 2 h after adminitration. A prolongation of the QTc-time could only be statistically confirmed for the higher dose. No differences in pharmacokinetic parameters were observed between the two doses.

Translated title of the contributionPlasma levels of Sotalol-HCl and effects on ECG intervals aftar parenteral administration in healthy volunteers
Original languageGerman
Pages (from-to)1058-1062
Number of pages5
JournalArzneimittel-Forschung/Drug Research
Volume37
Issue number9
StatePublished - 1987
Externally publishedYes

Fingerprint

Dive into the research topics of 'Plasma levels of Sotalol-HCl and effects on ECG intervals aftar parenteral administration in healthy volunteers'. Together they form a unique fingerprint.

Cite this